{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:39:32Z","timestamp":1760369972429,"version":"3.27.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.contraception.2024.110367","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T17:07:42Z","timestamp":1705338462000},"page":"110367","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5\u00a0mg intrauterine device vs Nova T copper 380\u00a0mm2 intrauterine device: Results of a phase 4 randomized controlled trial"],"prefix":"10.1016","volume":"133","author":[{"given":"Josep","family":"Perell\u00f3-Cap\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Estadella-Tarriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Gich-Saladich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bail\u00f3n-Queiruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Llurba-Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Calaf-Alsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.contraception.2024.110367_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2011.08.004","article-title":"Associations between recent contraceptive use and quality of life among women","volume":"85","author":"Williams","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2024.110367_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.contraception.2009.02.002","article-title":"Impact of different contraceptive methods on quality of life in rural women of the Jiangsu province in China","volume":"80","author":"Zhao","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110367_bib3","unstructured":"Faculty of Sexual & Reproductive Healthcare Clinical Guidance. Intrauterine Contraception: Faculty of Sexual & Reproductive Healthcare; 2015 (amended 2019). Available from: \u3008https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/ceuguidanceintrauterinecontraception\/\u3009 [last accessed: September 6, 2023]."},{"key":"10.1016\/j.contraception.2024.110367_bib4","unstructured":"Nova T. 380 Product information. Bayer Healthcare. Available from: \u3008https:\/\/www.bayer.com\/sites\/default\/files\/NOVA_T_380_EN_PI.pdf\u3009 [last accessed: September 6, 2023]."},{"issue":"1","key":"10.1016\/j.contraception.2024.110367_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110367_bib6","unstructured":"Mirena\u00ae, SmPC. Available from: \u3008https:\/\/www.pi.bayer.com\/sites\/g\/files\/vrxlpx33726\/files\/2022\u201301\/20211221_var_ap_BEC20783\u201318310_HCPI_Mirena_en_mt.pdf\u3009 [last accessed: September 6, 2023]."},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jval.2011.08.1729","article-title":"Development and validation of the SEC-QOL questionnaire in women using contraceptive methods","volume":"14","author":"Perez-Campos","year":"2011","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/humrep\/deq079","article-title":"Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system","volume":"25","author":"Heikinheimo","year":"2010","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.01.020","article-title":"Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center","volume":"84","author":"Bastianelli","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2024.110367_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1479-828X.2004.00206.x","article-title":"Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire","volume":"44","author":"Radesic","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib11","first-page":"1059","article-title":"Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system--Mirena","volume":"32","author":"Skrzypulec","year":"2008","journal-title":"Coll Antropol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0039-1683370","article-title":"Sexual function and quality of life in a cohort of Brazilian users of two kind of intrauterine contraceptives","volume":"41","author":"Ferreira","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.contraception.2024.110367_bib13","first-page":"1449","article-title":"Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey","volume":"8","author":"Zhao","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/humrep\/deu063","article-title":"Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study","volume":"29","author":"Heikinheimo","year":"2014","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/13625180903203154","article-title":"User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey","volume":"14","author":"Romer","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2015.12.014","article-title":"One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users","volume":"93","author":"Cristobal","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110367_bib17","unstructured":"Jaydess\u00ae, SmPC. Available from: \u3008https:\/\/www.medicines.org.uk\/emc\/medicine\/28672\/SPC\/Jaydess+13.5+mg+intrauterine+delivery+system\u3009 [last accessed: September 6, 2023]."},{"issue":"3","key":"10.1016\/j.contraception.2024.110367_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.contraception.2016.02.004","article-title":"A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents","volume":"93","author":"Gemzell-Danielsson","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2024.110367_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/13625187.2018.1433824","article-title":"Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5\u2009mg) after abortion for unintended pregnancy","volume":"23","author":"Caruso","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2024.110367_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110127","article-title":"Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: results of a three-year, single-centre, randomized Phase 4 study","volume":"127","author":"Perell\u00f3-Cap\u00f3","year":"2023","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2024.110367_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.contraception.2024.110367_bib23","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.contraception.2024.110367_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2012.04.001","article-title":"Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis","volume":"86","author":"Kelekci","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1743-6109.2011.02266.x","article-title":"Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices","volume":"9","author":"Enzlin","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.contraception.2024.110367_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100943","article-title":"Association of levonorgestrel intrauterine devices with stress reactivity, mental health, quality of life and sexual functioning: a systematic review","volume":"63","author":"B\u00fcrger","year":"2021","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110367_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12955-019-1157-2","article-title":"Health-related quality of life in undergraduate women using any contraceptive","volume":"17","author":"Leon-Larios","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.contraception.2024.110367_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110367_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-022-01657-6","article-title":"Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review","volume":"22","author":"Costescu","year":"2022","journal-title":"BMC Womens Health"},{"issue":"4","key":"10.1016\/j.contraception.2024.110367_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0010-7824(90)90046-X","article-title":"Long-term contraception with the levonorgestrel 20 mcg\/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study","volume":"42","author":"Sivin","year":"1990","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:47:38Z","timestamp":1729126058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S0010782424000064"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110367","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5\u00a0mg intrauterine device vs Nova T copper 380\u00a0mm2 intrauterine device: Results of a phase 4 randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110367"}}